YU194691A - Benzodiazepinoni - Google Patents

Benzodiazepinoni

Info

Publication number
YU194691A
YU194691A YU194691A YU194691A YU194691A YU 194691 A YU194691 A YU 194691A YU 194691 A YU194691 A YU 194691A YU 194691 A YU194691 A YU 194691A YU 194691 A YU194691 A YU 194691A
Authority
YU
Yugoslavia
Prior art keywords
benzodiazepinoni
infections
benzodiazepinones
formula
new
Prior art date
Application number
YU194691A
Other languages
English (en)
Inventor
M.C. Hsu
Donna Many Huryn
S.Y.K. Tam
Original Assignee
Hoffmann La Roche Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche Ag. filed Critical Hoffmann La Roche Ag.
Publication of YU194691A publication Critical patent/YU194691A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Novi benzodiazepinoni formule: i smeše koje sadrže iste za suzbijanje virusnih infekcija, uključujući infekcije virusom HIV.
YU194691A 1990-12-17 1991-12-17 Benzodiazepinoni YU194691A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62855190A 1990-12-17 1990-12-17

Publications (1)

Publication Number Publication Date
YU194691A true YU194691A (sh) 1994-01-20

Family

ID=24519378

Family Applications (1)

Application Number Title Priority Date Filing Date
YU194691A YU194691A (sh) 1990-12-17 1991-12-17 Benzodiazepinoni

Country Status (18)

Country Link
EP (1) EP0491218A1 (sh)
JP (1) JPH04275287A (sh)
KR (1) KR920012070A (sh)
CN (1) CN1062528A (sh)
AU (1) AU8974191A (sh)
BR (1) BR9105406A (sh)
CA (1) CA2057646A1 (sh)
CS (1) CS381891A3 (sh)
FI (1) FI915915A (sh)
HU (1) HUT59920A (sh)
IE (1) IE914369A1 (sh)
IL (1) IL100364A0 (sh)
IS (1) IS3792A7 (sh)
MX (1) MX9102580A (sh)
NO (1) NO914968L (sh)
PT (1) PT99821A (sh)
YU (1) YU194691A (sh)
ZA (1) ZA919850B (sh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW221687B (sh) * 1992-01-24 1994-03-11 Hoffmann La Roche
JPH06501502A (ja) * 1992-02-26 1994-02-17 エフ・ホフマン−ラ　ロシユ　アーゲー ベンゾジアゼピノン類
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
DE69333270T2 (de) 1992-03-11 2004-08-05 Narhex Ltd. Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
RU2126794C1 (ru) * 1992-03-11 1999-02-27 Нархекс Лимитед Аминопроизводные оксо- или гидроксизамещенных гидразинов, способ их получения и фармацевтические композиции для ингибирования ретровирусной протеазы
SI9300288A (sl) * 1992-06-16 1993-12-31 Hoffmann La Roche Benzodiazepini
US5519021A (en) * 1992-08-07 1996-05-21 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
US5939430A (en) * 1993-02-22 1999-08-17 Merrell Pharmaceuticals Inc. Combinations of retroviral inhibitors
KR100348138B1 (ko) * 1993-09-30 2002-11-23 시오노기세야쿠 가부시키가이샤 벤조락탐유도체
IT1297090B1 (it) * 1997-12-01 1999-08-03 Barbara Ensoli Tat di hiv-1 o suoi derivati, da soli od in combinazione, a scopo vaccinale, profilattico e terapeutico, contro l'aids i tumori e le
DE19920955C2 (de) * 1999-05-06 2002-11-28 Wacker Chemie Gmbh 2-(Benz-)Imidazol-,2-(Benz-)Oxazol- und 2-(Benz-)Thiazol-substituierte Silane und Verfahren zu deren Herstellung
WO2004026843A1 (en) * 2002-09-20 2004-04-01 Arrow Therapeutics Limited Benzodiazepine derivatives and pharmaceutical compositions containing them
US7196079B2 (en) * 2003-06-26 2007-03-27 Merck & Co, Inc. Benzodiazepine CGRP receptor antagonists
GB0406282D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
GB0406280D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Chemical compounds
GB0406279D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
CA2622592A1 (en) 2005-09-19 2007-03-29 Arrow Therapeutics Limited Benzodiazepine derivatives for treating hepatitis c infection
CN102516161A (zh) 2006-03-29 2012-06-27 弗·哈夫曼-拉罗切有限公司 作为mGluR2拮抗剂的吡啶和嘧啶衍生物
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
EP3105205A4 (en) * 2014-02-14 2017-08-02 Inception 2, Inc. Pyrazolone compounds and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL279830A (sh) * 1961-06-20
HUT61195A (en) * 1989-10-30 1992-12-28 Hoffmann La Roche Process for utilizing a benzodiazepine derivative and a phenylpyrrylketone derivative

Also Published As

Publication number Publication date
NO914968D0 (no) 1991-12-16
CS381891A3 (en) 1992-07-15
ZA919850B (en) 1992-08-26
FI915915A (fi) 1992-06-18
KR920012070A (ko) 1992-07-25
IE914369A1 (en) 1992-06-17
CA2057646A1 (en) 1992-06-18
AU8974191A (en) 1992-06-18
HUT59920A (en) 1992-07-28
IL100364A0 (en) 1992-09-06
BR9105406A (pt) 1992-08-25
JPH04275287A (ja) 1992-09-30
EP0491218A1 (en) 1992-06-24
FI915915A0 (fi) 1991-12-16
HU913960D0 (en) 1992-02-28
NO914968L (no) 1992-06-18
PT99821A (pt) 1992-12-31
IS3792A7 (is) 1992-06-18
MX9102580A (es) 1992-06-01
CN1062528A (zh) 1992-07-08

Similar Documents

Publication Publication Date Title
YU194691A (sh) Benzodiazepinoni
AU6613896A (en) Chemical compounds
FI964441A (fi) Yhdisteet, jotka ovat käyttökelpoisia retrovirusinfektioiden hoitoon
FI932032A0 (fi) Kinazolinderivat foer oekande av antitumoeraktivitet
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
GEP20002331B (en) Alkylated Raphamicine Derivatives
HK1026691A1 (en) Substituted benzimidazoles and their use for treating retroviral infection
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
ZA9710796B (en) Oxyiminopregnanecarbolactones.
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
DK0425650T3 (da) Antiinflammatoriske 4-aminophenolderivater
FI892454A0 (fi) Nya bensimidazolderivat, foerfarande foer framstaellning av desamma och farmaceutisk komposition innehaollande desamma.
JO1704B1 (en) New potent compounds
NZ308398A (en) 2-amino benzoxazin-4-one derivatives and medicaments
FI945000A (fi) Menetelmä (S)-amino-1-substituoitujen pyrrolidiinien valmistamiseksi
AU3170193A (en) Therapeutic nucleosides
TR199701298T1 (xx) Tetralinler.
DE69208681D1 (de) Verwendungen von 1,1,1,3,3,3-hexafluoropropan
ES2129053T3 (es) Nuevos derivados de fosfolipidos.
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
ES2120620T3 (es) Tiazoles antivirales.
DE3780157T2 (de) Verwendung von 4-butyl-1,2-diphenyl-pyrazolidin-3,5-dion als antivirales arzneimittel gegen aids.
GR1001405B (el) Ενώσεις 2-πιπεραζινόνης και η παραγωγή και η χρησιμοποίηση αυτών.
DE69112032T2 (de) Herstellung von Ethern.
SU1746666A1 (ru) Замещенные 3-аминометиленпирролидин-2,4-дионы, обладающие противосудорожной активностью